Dog /
FDA CVM · 2025 release 2,525 reports on file

Pekingese - FDA Adverse Event Profile

Adverse-event records for Pekingese (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 155 116.25 77.5 38.75 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Pekingese drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Pekingese ranks #70 by report volume among dog breeds - 100 of 2,525 reports (4.0%) recorded a death outcome.

#70
most-reported dog breed
4.0%
death-coded report share
593
Vomiting - top reaction
7.0 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

2,525

FDA CVM filings

Deaths Reported

100

of 2,525 reports

Death Rate

4.0%

death-coded share

Avg Age at Report

7.0 yr

6.6 kg avg weight

Death-Coded Outcome Share

Pekingese death-coded reports 4.0%
Cross-breed median

4.0% of 2,525 pekingese reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 6.6 kg (14.6 lbs)

Top Reported Reactions

Vomiting 593
Emesis 402
Lethargy (see also Central nervous system depression in 'Neurological') 297
Lack of efficacy (ectoparasite) - flea 223
Diarrhoea 173
Seizure NOS 158
Anorexia 115
Lack of efficacy - NOS 109
Pruritus 92
Lack of efficacy (endoparasite) - hookworm 82
Behavioural disorder NOS 79
Not eating 64
Ataxia 63
Other abnormal test result NOS 61
Decreased appetite 59

Most Referenced Drugs

Milbemycin Oxime + Spinosad 636
Spinosad 396
Afoxolaner 144
Ivermectin + Pyrantel As Pamoate Salt 134
Fluralaner Chew Tablets 101
Moxidectin 88
Oclacitinib Maleate 80
Carprofen 67
Fluralaner 13.64% 12-Week Chew 63
Milbemycin Oxime + Praziquantel 57
Pyrantel Pamoate;Sarolaner 57
Sarolaner 56
Nitenpyram 53
Selamectin 50
Imidacloprid + Moxidectin 49

Outcome Breakdown

Recovered/Normal
1,048 (45.5%)
Outcome Unknown
648 (28.1%)
Ongoing
409 (17.7%)
Recovered with Sequela
100 (4.3%)
Died
62 (2.7%)
Euthanized
38 (1.6%)

Gender Distribution

Male 1,303 (51.6%)
Female 1,147 (45.4%)
Unknown 68 (2.7%)
Mixed 7 (0.3%)

Reports by Year

Year Reports Trend
2010 119
2011 187
2012 299
2013 281
2014 236
2015 230
2016 197
2017 184
2018 155
2019 109
2020 117
2021 105
2022 84
2023 71
2024 101
2025 50

Pekingese Pet Health Insights

Pekingese accounts for 2,525 FDA adverse event reports, ranking #70 by volume among dog breeds, with 100 reports (4.0%) coded as a death outcome. Mean age at report: 7.0 years, average weight 6.6 kg (14.6 lbs).

Top reported signs: Vomiting (593), Emesis (402), Lethargy (see also Central nervous system depression in 'Neurological') (297). Most-referenced drug: Milbemycin Oxime + Spinosad (636 reports), followed by Spinosad (396) and Afoxolaner (144).

Outcome coding on 2,305 status-recorded reports is dominated by Recovered/Normal (45.5%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Pekingese?
There are 2,525 adverse event reports involving Pekingese in the FDA database, with 100 reports involving death (4.0% death rate). Pekingese ranks #70 by report volume.
What are the most common adverse reactions reported for Pekingese?
The most commonly reported adverse reactions for Pekingese are Vomiting (593 reports), Emesis (402 reports), Lethargy (see also Central nervous system depression in 'Neurological') (297 reports), Lack of efficacy (ectoparasite) - flea (223 reports), Diarrhoea (173 reports).
What drugs are most frequently associated with Pekingese adverse events?
The drugs most frequently referenced in Pekingese adverse event reports are Milbemycin Oxime + Spinosad (636 reports), Spinosad (396 reports), Afoxolaner (144 reports), Ivermectin + Pyrantel As Pamoate Salt (134 reports), Fluralaner Chew Tablets (101 reports).
What is the average age of Pekingese in adverse event reports?
The average age of Pekingese at the time of adverse event reports is 7.0 years, with an average weight of 6.6 kg (14.6 lbs).
Does a high number of adverse event reports mean Pekingese is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Pekingese safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.